Integrated Filing — IndAS
General information about company
| Scrip Code |
532321 |
| NSE Symbol |
ZYDUSLIFE |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE010B01027 |
| Name of company |
ZYDUS LIFESCIENCES LIMITED |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2026 |
| Date of end of financial year |
31-03-2027 |
| Date of board meeting when results were approved |
04-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
19-10-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Second quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
04-11-2026 10:50:00 |
| End date and time of board meeting |
04-11-2026 12:10:00 |
| Whether cash flow statement is applicable on company |
Yes |
| Type of cash flow statement |
Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Not applicable |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
7,90,960.00 |
15,92,660.00 |
|
Other income |
12,990.00 |
23,600.00 |
|
Total income |
8,03,950.00 |
16,16,260.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
1,38,710.00 |
2,63,830.00 |
| (b) |
Purchases of stock-in-trade |
1,26,020.00 |
2,54,940.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(49,290.00) |
(79,350.00) |
| (d) |
Employee benefit expense |
1,35,710.00 |
2,72,530.00 |
| (e) |
Finance costs |
18,700.00 |
34,300.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
60,450.00 |
1,13,450.00 |
| (f) |
Other Expenses |
| 1 |
Other expenses |
2,64,020.00 |
5,17,670.00 |
| 2 |
Net (gain) on foreign currency transactions |
(13,660.00) |
(19,350.00) |
|
Total other expenses |
2,50,360.00 |
4,98,320.00 |
|
Total expenses |
6,80,660.00 |
13,58,020.00 |
| 3 |
Total profit before exceptional items and tax |
1,23,290.00 |
2,58,240.00 |
| 4 |
Exceptional items |
130.00 |
(1,690.00) |
| 5 |
Total profit before tax |
1,23,420.00 |
2,56,550.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
49,870.00 |
87,460.00 |
| 8 |
Deferred tax |
(16,470.00) |
(18,230.00) |
| 9 |
Total tax expenses |
33,400.00 |
69,230.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
90,020.00 |
1,87,320.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
2,750.00 |
6,530.00 |
| 16 |
Total profit (loss) for period |
92,770.00 |
1,93,850.00 |
| 17 |
Other comprehensive income net of taxes |
100.00 |
(3,190.00) |
| 18 |
Total Comprehensive Income for the period |
92,870.00 |
1,90,660.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
92,550.00 |
1,88,590.00 |
|
Total profit or loss, attributable to non-controlling interests |
220.00 |
5,260.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
92,350.00 |
1,85,570.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
520.00 |
5,090.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
9,980.00 |
9,980.00 |
|
Face value of equity share capital |
1 |
1 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
9.28 |
18.84 |
|
Diluted earnings (loss) per share from continuing operations |
9.28 |
18.84 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
9.28 |
18.84 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
9.28 |
18.84 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Statement of Asset and Liabilities
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2026 |
| Date of end of reporting period |
30-09-2026 |
| Whether results are audited or unaudited |
Unaudited |
| Nature of report standalone or consolidated |
Consolidated |
|
Assets |
| 1 |
Non-current assets |
|
Property, plant and equipment |
9,27,620.00 |
|
Capital work-in-progress |
1,63,580.00 |
|
Investment property |
0.00 |
|
Goodwill |
7,81,790.00 |
|
Other intangible assets |
8,00,410.00 |
|
Intangible assets under development |
2,60,000.00 |
|
Biological assets other than bearer plants |
0.00 |
|
Investments accounted for using equity method |
1,23,190.00 |
|
Non-current financial assets |
|
|
Non-current investments |
3,45,190.00 |
|
Trade receivables, non-current |
0.00 |
|
Loans, non-current |
170.00 |
|
Other non-current financial assets |
|
| 1 |
Other Financial Assets |
3,480.00 |
|
Total of other non-current financial assets |
3,480.00 |
|
Total non-current financial assets |
3,48,840.00 |
|
Deferred tax assets (net) |
2,12,340.00 |
|
Other non-current assets |
|
| 1 |
Other non-current assets |
81,720.00 |
| 2 |
Assets for Current tax (Net) |
17,850.00 |
|
Total of other non-current assets |
99,570.00 |
|
Total non-current assets |
37,17,340.00 |
| 2 |
Current assets |
|
|
Inventories |
6,88,220.00 |
|
Current financial asset |
|
|
Current investments |
3,66,410.00 |
|
Trade receivables, current |
4,38,070.00 |
|
Cash and cash equivalents |
66,920.00 |
|
Bank balance other than cash and cash equivalents |
88,260.00 |
|
Loans, current |
470.00 |
|
Other current financial assets |
|
|
Total of other current financial assets |
43,450.00 |
|
Total current financial assets |
10,03,580.00 |
|
Current tax assets (net) |
|
|
Other current assets |
|
| 1 |
Other current assets |
1,51,550.00 |
|
Total of other current assets |
1,51,550.00 |
|
Total current assets |
18,43,350.00 |
| 3 |
Non-current assets classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account debit balances and related deferred tax Assets |
0.00 |
|
Total assets |
55,60,690.00 |
|
Equity and liabilities |
|
| 1 |
Equity |
|
|
Equity attributable to owners of parent |
|
|
Equity share capital |
9,980.00 |
|
Other equity |
27,71,750.00 |
|
Total equity attributable to owners of parent |
27,81,730.00 |
|
Non controlling interest |
2,50,550.00 |
|
Total equity |
30,32,280.00 |
| 2 |
Liabilities |
|
|
Non-current liabilities |
|
|
Non-current financial liabilities |
|
|
Borrowings, non-current |
4,10,620.00 |
|
Trade payables, non-current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
0.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
0.00 |
|
Total Trade payable |
0.00 |
|
Other non-current financial liabilities |
|
| 1 |
Lease liabilities |
65,810.00 |
| 2 |
Other financial liabilities |
19,360.00 |
|
Total of other non-current financial liabilities |
85,170.00 |
|
Total non-current financial liabilities |
4,95,790.00 |
|
Provisions, non-current |
46,300.00 |
|
Deferred tax liabilities (net) |
1,83,950.00 |
|
Deferred government grants, Non-current |
|
|
Other non-current liabilities |
|
| 1 |
Other Non-Current Liabilities |
20.00 |
|
Total of other non-current liabilities |
20.00 |
|
Total non-current liabilities |
7,26,060.00 |
|
Current liabilities |
|
|
Current financial liabilities |
|
|
Borrowings, current |
9,14,340.00 |
|
Trade payables, current |
|
|
(A) Total outstanding dues of micro enterprises and small enterprises |
14,450.00 |
|
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises |
2,81,310.00 |
|
Total Trade payable |
2,95,760.00 |
|
Other current financial liabilities |
|
| 1 |
Lease liabilities |
5,870.00 |
| 2 |
Other financial liabilities |
4,25,730.00 |
|
Total of other current financial liabilities |
4,31,600.00 |
|
Total current financial liabilities |
16,41,700.00 |
|
Other current liabilities |
57,560.00 |
| 1 |
Other current liabilities |
57,560.00 |
|
Total of other current liabilities |
57,560.00 |
|
Provisions, current |
63,480.00 |
|
Current tax liabilities (Net) |
39,610.00 |
|
Deferred government grants, Current |
0.00 |
|
Total current liabilities |
18,02,350.00 |
| 3 |
Liabilities directly associated with assets in disposal group classified as held for sale |
0.00 |
| 4 |
Regulatory deferral account credit balances and related deferred tax liability |
0.00 |
|
Total liabilities |
25,28,410.00 |
|
Total equity and liabilites |
55,60,690.00 |
|
Disclosure of notes on assets and liabilities |
|
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| Date of end of reporting
period |
30-09-2026 |
30-09-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Pharmaceuticals |
6,55,820.00 |
12,85,630.00 |
| 2 |
Consumer products |
1,12,570.00 |
2,56,160.00 |
| 3 |
Medical technologies |
22,570.00 |
50,870.00 |
|
Total Segment Revenue |
7,90,960.00 |
15,92,660.00 |
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
7,90,960.00 |
15,92,660.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Pharmaceuticals |
1,31,860.00 |
2,56,380.00 |
| 2 |
Consumer products |
710.00 |
16,840.00 |
| 3 |
Medical technologies |
(9,280.00) |
(14,980.00) |
|
Total Profit before tax |
1,23,290.00 |
2,58,240.00 |
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
1,23,290.00 |
2,58,240.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Pharmaceuticals |
38,84,250.00 |
38,84,250.00 |
| 2 |
Consumer products |
10,35,080.00 |
10,35,080.00 |
| 3 |
Medical technologies |
6,41,360.00 |
6,41,360.00 |
|
Total Segment Asset |
55,60,690.00 |
55,60,690.00 |
|
Un-allocable Assets |
0.00 |
0.00 |
|
Net Segment Asset |
55,60,690.00 |
55,60,690.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Pharmaceuticals |
14,39,020.00 |
14,39,020.00 |
| 2 |
Consumer products |
4,43,860.00 |
4,43,860.00 |
| 3 |
Medical technologies |
6,45,530.00 |
6,45,530.00 |
|
Total Segment Liabilities |
25,28,410.00 |
25,28,410.00 |
|
Un-allocable Liabilities |
0.00 |
0.00 |
|
Net Segment Liabilities |
25,28,410.00 |
25,28,410.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-07-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Items that will not be reclassified to profit or loss |
8,870.00 |
11,500.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
8,870.00 |
11,500.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
(280.00) |
(200.00) |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
|
Total Amount of items that will be reclassified to profit and loss |
|
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
9,050.00 |
14,890.00 |
| 5 |
Total Other comprehensive income |
100.00 |
(3,190.00) |
Cash flow statement, indirect
Amount in (Lakhs)
| Particulars |
Year ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
| B |
Date of end of reporting period |
30-09-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
|
Statement of cash flows |
|
|
Cash flows from used in operating
activities |
|
|
Profit before tax |
2,56,550.00 |
|
Adjustments for reconcile profit (loss) |
|
|
Adjustments for finance costs |
28,520.00 |
|
Adjustments for decrease (increase) in inventories |
(1,05,580.00) |
|
Adjustments for decrease (increase) in trade receivables, current |
1,45,630.00 |
|
Adjustments for decrease (increase) in trade receivables, non-current
|
0.00 |
|
Adjustments for decrease (increase) in other current assets |
1,690.00 |
|
Adjustments for decrease (increase) in other non-current assets |
0.00 |
|
Adjustments for other financial assets, non-current |
0.00 |
|
Adjustments for other financial assets, current |
0.00 |
|
Adjustments for other bank balances |
0.00 |
|
Adjustments for increase (decrease) in trade payables, current |
(38,760.00) |
|
Adjustments for increase (decrease) in trade payables, non-current |
0.00 |
|
Adjustments for increase (decrease) in other current liabilities |
17,230.00 |
|
Adjustments for increase (decrease) in other non-current liabilities
|
0.00 |
|
Adjustments for depreciation and amortisation expense |
1,13,450.00 |
|
Adjustments for impairment loss reversal of impairment loss recognised
in profit or loss |
0.00 |
|
Adjustments for provisions, current |
12,060.00 |
|
Adjustments for provisions, non-current |
3,510.00 |
|
Adjustments for other financial liabilities, current |
0.00 |
|
Adjustments for other financial liabilities, non-current |
4,910.00 |
|
Adjustments for unrealised foreign exchange losses gains |
(14,850.00) |
|
Adjustments for dividend income |
130.00 |
|
Adjustments for interest income |
24,270.00 |
|
Adjustments for share-based payments |
0.00 |
|
Adjustments for fair value losses (gains) |
1,210.00 |
|
Adjustments for undistributed profits of associates |
0.00 |
|
Other adjustments for which cash effects are investing or financing
cash flow |
100.00 |
|
Other adjustments to reconcile profit (loss) |
0.00 |
|
Other adjustments for non-cash items |
5,000.00 |
|
Share of profit and loss from partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Total adjustments for reconcile
profit (loss) |
1,49,720.00 |
|
Net cash flows from (used in)
operations |
4,06,270.00 |
|
Dividends received |
0.00 |
|
Interest paid |
0.00 |
|
Interest received |
0.00 |
|
Income taxes paid (refund) |
90,040.00 |
|
Other inflows (outflows) of cash |
0.00 |
|
Net cash flows from (used in)
operating activities |
3,16,230.00 |
|
Cash flows from used in
investing activities |
|
|
Cash flows from losing control of subsidiaries or other businesses |
0.00 |
|
Cash flows used in obtaining control of subsidiaries or other businesses |
1,56,300.00 |
|
Other cash receipts from sales of equity or debt instruments of other
entities |
6,250.00 |
|
Other cash payments to acquire equity or debt instruments of other entities
|
48,340.00 |
|
Other cash receipts from sales of interests in joint ventures |
0.00 |
|
Other cash payments to acquire interests in joint ventures |
0.00 |
|
Cash receipts from share of profits of partnership firm or association of
persons or limited liability partnerships |
0.00 |
|
Cash payment for investment in partnership firm or association of persons or
limited liability partnerships |
0.00 |
|
Proceeds from sales of property, plant and equipment |
1,270.00 |
|
Purchase of property, plant and equipment |
1,26,120.00 |
|
Proceeds from sales of investment property |
0.00 |
|
Purchase of investment property |
0.00 |
|
Proceeds from sales of intangible assets |
0.00 |
|
Purchase of intangible assets |
0.00 |
|
Proceeds from sales of intangible assets under development |
0.00 |
|
Purchase of intangible assets under development |
0.00 |
|
Proceeds from sales of goodwill |
0.00 |
|
Purchase of goodwill |
0.00 |
|
Proceeds from biological assets other than bearer plants |
0.00 |
|
Purchase of biological assets other than bearer plants |
0.00 |
|
Proceeds from government grants |
0.00 |
|
Proceeds from sales of other long-term assets |
0.00 |
|
Purchase of other long-term assets |
0.00 |
|
Cash advances and loans made to other parties |
250.00 |
|
Cash receipts from repayment of advances and loans made to other parties |
0.00 |
|
Cash payments for future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Cash receipts from future contracts, forward contracts, option contracts and
swap contracts |
0.00 |
|
Dividends received |
130.00 |
|
Interest received |
17,180.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
(1,06,760.00) |
|
Net cash flows from (used in)
investing activities |
(4,12,940.00) |
|
Cash flows from used in
financing activities |
|
|
Proceeds from changes in ownership interests in subsidiaries |
0.00 |
|
Payments from changes in ownership interests in subsidiaries |
0.00 |
|
Proceeds from issuing shares |
0.00 |
|
Proceeds from issuing other equity instruments |
0.00 |
|
Payments to acquire or redeem entity's shares |
1,10,630.00 |
|
Payments of other equity instruments |
0.00 |
|
Proceeds from exercise of stock options |
0.00 |
|
Proceeds from issuing debentures notes bonds etc |
0.00 |
|
Proceeds from borrowings |
1,93,110.00 |
|
Repayments of borrowings |
83,740.00 |
|
Payments of lease liabilities |
5,260.00 |
|
Dividends paid |
9,970.00 |
|
Interest paid |
28,450.00 |
|
Income taxes paid (refund) |
0.00 |
|
Other inflows (outflows) of cash |
1,22,350.00 |
|
Net cash flows from (used in)
financing activities |
77,410.00 |
|
Net increase (decrease) in cash
and cash equivalents before effect of exchange rate changes |
(19,300.00) |
|
Effect of exchange rate changes
on cash and cash equivalents |
|
|
Effect of exchange rate changes on cash and cash equivalents |
700.00 |
|
Net increase (decrease) in cash
and cash equivalents |
(18,600.00) |
|
Cash and cash equivalents cash flow statement at beginning of period
|
85,520.00 |
|
Cash and cash equivalents cash
flow statement at end of period |
66,920.00 |